skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: 5i,
Im looking into investing into the healthcare sector in the US market. What companies would you recommend for growth?
Read Answer Asked by D on February 20, 2018
Q: ATE is set to release final Phase 2b results of their lead drug ATB-346, in 4weeks. I'm curious if you have any relevant information on the outlook of this drug and the company overall? I understand GUD has funds deployed here. And my main question is if the trial results show less GI tract bleeding (the issue with prolonged doses of Naproxen) and better efficacy results than Aleve then how could the drug or company's valuation be estimated? Sales numbers for Bayer's Aleve that could be extrapolated? thanks
Read Answer Asked by Gordon on February 16, 2018
Q: SNY (not in your database) recently reported a poor quarter and so-so guidance. On the other hand, the P/E is now less than 12x, the dividend is substantial, and the pipeline should be broad enough to protect against single-drug risk. My sense is that it's long-term-investable, but less attractive than other beaten-down pharma blue-chips (say, LLY); your opinion?
Read Answer Asked by John on February 16, 2018
Q: What would be your favourite healthcare stocks in Canada and Us?
Thank you
Read Answer Asked by Josette on February 06, 2018
Q: Cheers. First of all thanks for recent Avo encouragement. Worked out very well.

What are the consequences to Gud if companies like Amazon get into the pharmaceutical business in a big way? Also there is lots of talk by governments and insurance companies of signing contracts with drug providers where drug costs are lowered by 35-40%. Quebec signed such a contract awhile ago and recent reports suggest the other provinces are also in the process of doing so. I believe this is the area where Jonathan Goodman and his team have their expertise and previous success. I have a 3 year invested interest in Gud and wondering how these events are affecting Guds future potential and even its present share price decline?
Would like to hear your valued thots on this.
Thanks
Terry
Read Answer Asked by Terry on February 02, 2018
Q: Hi Peter, Ryan, and Team,

I manage a TFSA for my daughter-in-law. She holds 165 shares of GUD and is presently down $419. I know that you're still positive on GUD, but she's beginning to lose patience. Would you be OK with selling GUD to buy COV (realizing its size makes it more risky) or perhaps buying XHC (which we can do commission free) to stay in the same sector in an otherwise balanced portfolio?
She's 49 years old and is using her TFSA as forced savings by adding $100 each month. (I invest the $100 in a commission-free ETF by looking at the 'best ones' and invest in the one that's down the most on the day that the $100 appears in her account.)

Thanks in advance for your insight.

Read Answer Asked by Jerry on February 02, 2018
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!